Innate Pharma SA Noncurrent Financial Assets
Innate Pharma SA (IPHA) had Noncurrent Financial Assets of EUR 10.46 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:NoncurrentFinancialAssets · last filed 2026-04-01
- 2025-12-31: Noncurrent Financial Assets 10.46M EUR.
- 2025-06-30: Noncurrent Financial Assets 10.39M EUR.
- 2024-12-31: Noncurrent Financial Assets 10.28M EUR.
- 2024-06-30: Noncurrent Financial Assets 10.35M EUR.
| Period end | Noncurrent Financial Assets | Noncurrent Financial Assets as first filed |
|---|---|---|
| 2025-12-31 | 10.46M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 10.39M EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 10.28M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 10.35M EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | 9.80M EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 35.79M EUR 6-K · filed 2024-09-12 | |
| 2022-12-31 | 35.12M EUR 20-F · filed 2026-04-01 | |
| 2022-06-30 | 34.81M EUR 6-K · filed 2023-09-14 | 34.81M EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 39.88M EUR 20-F · filed 2025-04-30 | |
| 2021-06-30 | 40.08M EUR 6-K · filed 2022-09-15 | 40.08M EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 38.93M EUR 20-F · filed 2023-04-06 | |
| 2020-06-30 | 36.87M EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | 37.01M EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 35.18M EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | 60.47M EUR 20-F · filed 2020-04-24 |